Adbry

Active Ingredient(s): Tralokinumab
FDA Approved: * December 27, 2021
Pharm Company: * LEO PHARMA AS
Category: Skin Care

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Adbry Overview

Tralokinumab sold under the brand name Adtralza among others, is a human monoclonal antibody used for the treatment of atopic dermatitis.[1][3] Tralokinumabis targets the cytokine interleukin 13.[5] The most common side effects include upper respiratory tract infections (colds and other infections of the nose and throat), reactions at the injection site, and redness and discomfort in the eye.[3] Tralokinumab was approved for medi...

Read more Adbry Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Tralokinumab

Recent Adbry Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Tralokinumab
  • Injection: 150mg/ml
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Tralokinumab or a similar ingredient: (2 results)